Pascal Heberling

Karen H. Bechtel, PPD Board of Directors

Head of Healthcare, Private Equities, ADIA

Pascal Heberling is Head of Healthcare, Private Equities, of the Abu Dhabi Investment Authority (ADIA), which he joined in 2014. He is a member of the executive committee of ADIA's private equities department and a designee of one or more affiliates of ADIA on the holding company boards of ADT and PPD.

Prior to ADIA, Mr. Heberling was a partner at Cinven, a private equity firm, based in London, where he spent 12 years following an earlier career in investment banking at Merrill Lynch. He previously served as a non-executive director on a number of company boards, including those of Spire Healthcare, Numericable, and Springer Science+Business Media.

Mr. Heberling graduated summa cum laude from the Institut d’Études Politiques de Paris and holds an M.A. and an MBA from the University of Toronto.

Contact Legal Notices Modern Slavery Transparency Statement Privacy Policy

© 2018 Pharmaceutical Product Development, LLC. All rights reserved.